Pablo García‐Pavía
Universidad Francisco de Vitoria(ES)Hospital La Paz Institute for Health Research(ES)
Publications by Year
Research Areas
Cardiomyopathy and Myosin Studies, Amyloidosis: Diagnosis, Treatment, Outcomes, Cardiovascular Effects of Exercise, Cardiovascular Function and Risk Factors, Parathyroid Disorders and Treatments
Most-Cited Works
- → 2023 ESC Guidelines for the management of cardiomyopathies(2023)2,116 cited
- → Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction(2015)1,131 cited
- → Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial(2020)1,123 cited
- → Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases(2021)1,092 cited
- → Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies(2016)465 cited
- → Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy(2024)387 cited